Clinical trial
Biomarker Study of Acamprosate in Schizophrenia
NCT00688324 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Study of Acamprosate in Schizophrenia
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- February 29, 2012
- Enrollment
- 36 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
schizoaffective disorder, schizophrenia